With Celgene Deal, Forma Makes First Foray Into Clinical Development
This article was originally published in The Pink Sheet Daily
Executive Summary
Forma Therapeutics has signed its largest and most ambitious oncology drug-discovery and development collaboration to date, in the exciting but early-stage area of protein homeostasis. Its new partner Celgene is no stranger to making big bets on promising cancer companies.